Literature DB >> 15256551

The bifunctional peptidoglycan lysin of Streptococcus agalactiae bacteriophage B30.

David G Pritchard1, Shengli Dong1, John R Baker1, Jeffrey A Engler1.   

Abstract

A group B streptococcal (GBS) bacteriophage lysin gene was cloned and expressed in Escherichia coli. The purified recombinant enzyme, calculated to have a molecular mass of 49 677 Da, lysed GBS cells. The susceptibility of GBS cells to lysis by the enzyme depended upon the growth stage at which they were harvested, with early exponential phase cells most sensitive. Calcium ions enhanced the activity of the enzyme. The enzyme also lysed other beta-haemolytic streptococci, including groups A, C, E and G streptococci, but not common oral streptococci, including Streptococcus mutans. The generation of both reducing activity and N-terminal alanine residues during lysis indicated that the lysin is a bifunctional enzyme, possessing both glycosidase and endopeptidase activities. This is consistent with the presence of two conserved sequence domains, an Acm (acetylmuramidase) domain associated with lysozyme activity, and a CHAP (cysteine, histidine-dependent amidohydrolases/peptidases) domain associated with endopeptidase activity. Site-directed mutagenesis of conserved cysteine and histidine residues in the CHAP domain and conserved aspartate and glutamate residues in the Acm domain confirmed their importance for lysozyme and endopeptidase activity respectively.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15256551     DOI: 10.1099/mic.0.27063-0

Source DB:  PubMed          Journal:  Microbiology (Reading)        ISSN: 1350-0872            Impact factor:   2.777


  51 in total

1.  Essential PcsB putative peptidoglycan hydrolase interacts with the essential FtsXSpn cell division protein in Streptococcus pneumoniae D39.

Authors:  Lok-To Sham; Skye M Barendt; Kimberly E Kopecky; Malcolm E Winkler
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-17       Impact factor: 11.205

2.  The cell lysis activity of the Streptococcus agalactiae bacteriophage B30 endolysin relies on the cysteine, histidine-dependent amidohydrolase/peptidase domain.

Authors:  David M Donovan; Juli Foster-Frey; Shengli Dong; Geneviève M Rousseau; Sylvain Moineau; David G Pritchard
Journal:  Appl Environ Microbiol       Date:  2006-07       Impact factor: 4.792

3.  Endopeptidase and glycosidase activities of the bacteriophage B30 lysin.

Authors:  John R Baker; Chengbao Liu; Shengli Dong; David G Pritchard
Journal:  Appl Environ Microbiol       Date:  2006-10       Impact factor: 4.792

4.  LambdaSa1 and LambdaSa2 prophage lysins of Streptococcus agalactiae.

Authors:  David G Pritchard; Shengli Dong; Marion C Kirk; Robert T Cartee; John R Baker
Journal:  Appl Environ Microbiol       Date:  2007-09-28       Impact factor: 4.792

Review 5.  Recombinant Endolysins as Potential Therapeutics against Antibiotic-Resistant Staphylococcus aureus: Current Status of Research and Novel Delivery Strategies.

Authors:  Hamed Haddad Kashani; Mathias Schmelcher; Hamed Sabzalipoor; Elahe Seyed Hosseini; Rezvan Moniri
Journal:  Clin Microbiol Rev       Date:  2017-11-29       Impact factor: 26.132

6.  TgaA, a VirB1-like component belonging to a putative type IV secretion system of Bifidobacterium bifidum MIMBb75.

Authors:  Simone Guglielmetti; Silvia Balzaretti; Valentina Taverniti; Matteo Miriani; Christian Milani; Alessio Scarafoni; Silvia Corona; Alessandro Ciranna; Stefania Arioli; Ville Santala; Stefania Iametti; Francesco Bonomi; Marco Ventura; Diego Mora; Matti Karp
Journal:  Appl Environ Microbiol       Date:  2014-06-20       Impact factor: 4.792

7.  PlyC: a multimeric bacteriophage lysin.

Authors:  Daniel Nelson; Raymond Schuch; Peter Chahales; Shiwei Zhu; Vincent A Fischetti
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-03       Impact factor: 11.205

Review 8.  Recombinant bacteriophage lysins as antibacterials.

Authors:  Mark Fenton; Paul Ross; Olivia McAuliffe; Jim O'Mahony; Aidan Coffey
Journal:  Bioeng Bugs       Date:  2010 Jan-Feb

Review 9.  Bacteriophage endolysins as novel antimicrobials.

Authors:  Mathias Schmelcher; David M Donovan; Martin J Loessner
Journal:  Future Microbiol       Date:  2012-10       Impact factor: 3.165

10.  SipA is required for pilus formation in Streptococcus pyogenes serotype M3.

Authors:  Dorothea Zähner; June R Scott
Journal:  J Bacteriol       Date:  2007-11-09       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.